Accessibility Menu
Hitiq logo

Hitiq(ASX) HIQ

Market CapA$5.67MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-97%
5 Year-95%
1 Year-71%
1 Month-25%
A$0.01
+20.00%
+0.00Today
Hitiq last closing stock price
MetricPriceDate
Last closeAUD 0.012026-09-08
Hitiq stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+20%AUD 0.012026-09-01
1 month-25%AUD 0.012026-08-07
3 month-40%AUD 0.012026-06-10
Year to date-71.43%AUD 0.022025-12-31
1 year-71.43%AUD 0.022025-09-08
3 year-71.43%AUD 0.022023-09-07
5 year-94.58%AUD 0.112021-09-09
Since inception-96.91%AUD 0.162021-06-16

Hitiq Financials at a Glance

Market Cap

A$5.67MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$2.38M

Net Income (TTM)

-A$13.31M

EPS (TTM)

-A$0.01

P/E Ratio

-0.46

Dividend

A$0.00

Beta (Volatility)

0.00 (Low)

Price

A$0.01

Volume

2,314,972

Open

A$0.01

Previous Close

A$0.01

Daily Range

A$0.01 - A$0.01

52-Week Range

A$0.00 - A$0.04

Estimated Earnings Date

Nov 28, 2024

HIQ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hitiq

HITIQ Limited is an Australian company dedicated to developing advanced technology for concussion management. The company’s innovative Nexus software platform provides critical data and insights on head impacts, enhancing athlete care. HITIQ also offers CoVR, a virtual reality system for cognitive assessments, and CSX, a sideline tool for concussion evaluation.

Products and Services
  • Nexus software platform for head impact data analysis
  • CoVR, a virtual reality system for cognitive function assessment
  • CSX, a sideline tool for concussion evaluation and record-keeping
Growth Outlook
  • Expansion into new markets is anticipated to drive revenue growth
  • Increased awareness of concussion management is boosting demand for services
  • Partnerships with sports organizations are expected to enhance product adoption
Financial Highlights
  • Recent quarterly revenue of 250,674 AUD shows potential for growth
  • Trailing twelve months (TTM) revenue of 2,500,000 AUD indicates a solid foundation
  • Operating expenses have been managed, with a focus on R&D investments
HITIQ Limited is positioned in the healthcare information services sector, focusing on concussion management technology. The company’s innovative products aim to improve athlete safety and care, addressing a growing concern in sports and healthcare. With a market capitalization of approximately 5.6 million AUD, HITIQ is actively trading and has shown resilience in a competitive landscape. The recent quarterly revenue reflects a commitment to growth, while strategic partnerships and market expansion efforts are likely to enhance future performance. Investors may find HITIQ's focus on technology and athlete safety appealing as the demand for effective concussion management solutions continues to rise.
AI Generated • Aug 22, 2026

Industry

Health Care Technology

CEO

Michael Dean Vegar

Headquarters

Melbourne, VIC 3205, AU

HIQ Financials

Key Financial Metrics (TTM)

Gross Margin

79.38%

Operating Margin

-1758.95%

Net Income Margin

-1665.46%

Return on Equity

106.16%

Return on Capital

N/A

Return on Assets

-354.62%

Earnings Yield

-2.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$5.67MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.13B

Volume

2.31M

Avg. Volume

1.82M

Financials (TTM)

Gross Profit

-A$1.89M

Operating Income

-A$12.21M

EBITDA

-A$12.13M

Operating Cash Flow

-A$8.32M

Capital Expenditure

-A$59.59K

Free Cash Flow

-A$8.38M

Cash & ST Invst.

A$173.64K

Total Debt

A$2.27M

Hitiq Performance Analysis

Hitiq annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 774,26026.4%
20242024-06-30AUD 1,123,00045.0%
20252025-06-30AUD 673,250-40.0%
20262026-06-30AUD 366,334-45.6%
Hitiq sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3153.5%
Q42025-06-30-4.5%
Q22025-12-31-74.5%
Q42026-06-30-53.9%
Hitiq annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.02-32.8%
20242024-06-30AUD -0.01-62.9%
20252025-06-30AUD -0.0270.7%
20262026-06-30AUD -0.01-31.2%
Hitiq sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-83.3%
Q42025-06-3018.2%
Q22025-12-3123.6%
Q42026-06-303.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$115.66K

-82.8%

Gross Profit

A$93.82K

-77.9%

Gross Margin

81.11%

N/A

Market Cap

A$5.67MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$226.94K

N/A

Employees

25

N/A

Net Income

-A$3.20M

-92.6%

EBITDA

-A$3.29M

-164.7%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$173.64K

-70.3%

Total Debt

A$2.27M

-28.9%

Accounts Receivable

A$1.24M

-43.5%

Inventory

A$0.00

N/A

Long Term Debt

A$89.18K

-68.8%

Short Term Debt

A$2.18M

-25.0%

Return on Assets

-3.55%

N/A

Return on Invested Capital

1.04%

N/A

Free Cash Flow

-A$550.74K

+80.8%

Operating Cash Flow

-A$519.72K

+81.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ACR.AXAcrux Limited
A$0.01+0.00%
PER.AXPercheron Therapeutics Limited
A$0.00-33.33%
IVX.AXInvion Limited
A$0.04-5.00%
CAN.AXCann Group Limited
A$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$46.34-0.10%
INTCIntel
$95.80+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$72.37+0.00%
NOKNokia
$10.03+0.03%

Questions About HIQ

What is the current price of Hitiq?

Hitiq is trading at A$0.01 per share.

What is the 52-week range for Hitiq?

Over the past 52 weeks, Hitiq has traded between A$0.00 and A$0.04.

How much debt does Hitiq have?

As of the most recent reporting period, Hitiq reported total debt of A$2.27M.

How much cash does Hitiq have on hand?

Hitiq reported A$173.64K in cash and cash equivalents in its most recent financial results.

What is Hitiq’s dividend yield?

Hitiq does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.